Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

Objective: To compare the effect of sitagliptin (100 mg) vs glimepiride (1–3 mg) as add-on therapy in Indian type 2 diabetes (T2DM) patients on treatment with insulin and metformin (SWIM study). Research design and methods: This 24-week, controlled, open-label study randomized T2DM patients (n = 44...

Full description

Bibliographic Details
Main Authors: Jothydev Kesavadev, Pradeep Babu Sadasivan Pillai, Arun Shankar, Gopika Krishnan, Sunitha Jothydev
Format: Article
Language:English
Published: Bioscientifica 2017-11-01
Series:Endocrine Connections
Subjects:
glimepiride
insulin
metformin
sitagliptin
type 2 diabetes
Online Access:http://www.endocrineconnections.com/content/6/8/748.full

Internet

http://www.endocrineconnections.com/content/6/8/748.full

Similar Items